Vistagen Therapeutics Statistics
Total Valuation
VTGN has a market cap or net worth of $123.34 million. The enterprise value is $62.51 million.
Important Dates
The next estimated earnings date is Friday, November 7, 2025, after market close.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VTGN has 30.68 million shares outstanding. The number of shares has increased by 23.99% in one year.
| Current Share Class | 30.68M |
| Shares Outstanding | 30.68M |
| Shares Change (YoY) | +23.99% |
| Shares Change (QoQ) | +1.17% |
| Owned by Insiders (%) | 0.33% |
| Owned by Institutions (%) | 36.23% |
| Float | 21.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 194.21 |
| Forward PS | n/a |
| PB Ratio | 2.07 |
| P/TBV Ratio | 2.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 96.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.98, with a Debt / Equity ratio of 0.04.
| Current Ratio | 5.98 |
| Quick Ratio | 5.66 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -69.05% and return on invested capital (ROIC) is -44.94%.
| Return on Equity (ROE) | -69.05% |
| Return on Assets (ROA) | -40.86% |
| Return on Invested Capital (ROIC) | -44.94% |
| Return on Capital Employed (ROCE) | -103.25% |
| Revenue Per Employee | $11,333 |
| Profits Per Employee | -$978,596 |
| Employee Count | 57 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VTGN has paid $7,000 in taxes.
| Income Tax | 7,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.62% in the last 52 weeks. The beta is 0.57, so VTGN's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | +27.62% |
| 50-Day Moving Average | 3.72 |
| 200-Day Moving Average | 2.85 |
| Relative Strength Index (RSI) | 52.17 |
| Average Volume (20 Days) | 494,705 |
Short Selling Information
The latest short interest is 1.34 million, so 4.36% of the outstanding shares have been sold short.
| Short Interest | 1.34M |
| Short Previous Month | 1.34M |
| Short % of Shares Out | 4.36% |
| Short % of Float | 6.10% |
| Short Ratio (days to cover) | 2.09 |
Income Statement
In the last 12 months, VTGN had revenue of $646,000 and -$55.78 million in losses. Loss per share was -$1.79.
| Revenue | 646,000 |
| Gross Profit | 646,000 |
| Operating Income | -59.65M |
| Pretax Income | -55.77M |
| Net Income | -55.78M |
| EBITDA | -59.49M |
| EBIT | -59.65M |
| Loss Per Share | -$1.79 |
Full Income Statement Balance Sheet
The company has $63.18 million in cash and $2.36 million in debt, giving a net cash position of $60.82 million or $1.98 per share.
| Cash & Cash Equivalents | 63.18M |
| Total Debt | 2.36M |
| Net Cash | 60.82M |
| Net Cash Per Share | $1.98 |
| Equity (Book Value) | 56.77M |
| Book Value Per Share | 1.94 |
| Working Capital | 55.56M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$50.07 million and capital expenditures -$214,000, giving a free cash flow of -$50.29 million.
| Operating Cash Flow | -50.07M |
| Capital Expenditures | -214,000 |
| Free Cash Flow | -50.29M |
| FCF Per Share | -$1.64 |
Full Cash Flow Statement Margins
| Gross Margin | 100.00% |
| Operating Margin | -9,233.13% |
| Pretax Margin | -8,633.59% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VTGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.99% |
| Shareholder Yield | -23.99% |
| Earnings Yield | -45.23% |
| FCF Yield | -40.77% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | 263.63% |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 7, 2023. It was a reverse split with a ratio of 1:30.
| Last Split Date | Jun 7, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
VTGN has an Altman Z-Score of -6.57 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.57 |
| Piotroski F-Score | 1 |